1
|
Vescovi AL, Galli R and Reynolds BA: Brain
tumour stem cells. Nat Rev Cancer. 6:425–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S,
Ge R, Jiang S, Li G, Chen Y, et al: microRNA-146b inhibits glioma
cell migration and invasion by targeting MMPs. Brain Res.
1269:158–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Badiga AV, Chetty C and Kesanakurti D:
MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma
cells. PloS One. 6:e206142011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
10
|
Xiao B, Tan L, He B, Liu Z and Xu R:
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma
cells. J Transi Med. 11:1722013. View Article : Google Scholar
|
11
|
Hui W, Yuntao L and Lun L: MicroRNA-195
inhibits the proliferation of human glioma cells by directly
targeting cyclin D1 and cyclin E1. PloS One. 8:e549322013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang C, Ge S, Hu C, Yang N and Zhang J:
MiRNA-218, a new regulator of HMGB1, suppresses cell migration and
invasion in non-small cell lung cancer. Acta Biochim Biophys Sin
(Shanghai). 45:1055–1061. 2013. View Article : Google Scholar
|
13
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Prudnikova TY, Mostovich LA, Kashuba VI,
Ernberg I, Zabarovsky ER and Grigorieva EV: miRNA-218 contributes
to the regulation of D-glucuronyl C5-epimerase expression in normal
and tumor breast tissues. Epigenetics. 7:1109–1114. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Xia H, Yan Y, Hu M, et al: MiR-218
sensitizes glioma cells to apoptosis and inhibits tumorigenicity by
regulating ECOP-mediated suppression of nf-κb activity. Neuro
Oncol. 15:413–422. 2013. View Article : Google Scholar :
|
16
|
Zhang JM, Sun CY, Yu SZ, et al:
Relationship between miR-218 and CDK6 expression and their
biological impact on glioma cell proliferation and apoptosis.
Zhonghua Bing Li Xue Za Zhi. 40:454–459. 2011.PubMed/NCBI
|
17
|
Hertzog JH, Campbell JK, Dalton HJ and
Hauser GJ: Propofol anesthesia for invasive procedures in
ambulatory and hospitalized children: experience in the pediatric
intensive care unit. Pediatrics. 103:E301999. View Article : Google Scholar : PubMed/NCBI
|
18
|
Altenburg JD, Harvey KA, McCray S, Xu Z
and Siddiqui RA: A novel 2,6-diisopropylphenyl-docosahexaenoamide
conjugate induces apoptosis in T cell acute lymphoblastic leukemia
cell lines. Biochem Biophys Res Commun. 411:427–432. 2011.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Mammoto T, Mukai M, Mammoto A, et al:
Intravenous anesthetic, propofol inhibits invasion of cancer cells.
Cancer Lett. 184:165–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Miao Y, Zhang Y, Wan H, Chen L and Wang F:
GABA-receptor agonist, propofol inhibits invasion of colon
carcinoma cells. Biomed Pharmacother. 64:583–588. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang J, Zhang D, Wu GQ, Feng ZY and Zhu
SM: Propofol inhibits the adhesion of hepatocellular carcinoma
cells by upregulating microRNA-199a and downregulating MMP-9
expression. Hepatobiliary & Pancreatic Diseases International.
12:305–309. 2013. View Article : Google Scholar
|
22
|
Inada T, Kubo K and Shingu K: Possible
link between cyclooxygenase-inhibiting and antitumor properties of
propofol. J Anesth. 25:569–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Parsons DW, Jones S, Zhang X, et al: An
integrated genomic analysis of human glioblastoma multiforme.
Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Siddiqui RA, Zerouga M, Wu M, et al:
Anticancer properties of propofol-docosahexaenoate and
propofol-eicosapentaenoate on breast cancer cells. Breast Cancer
Res. 7:R645–R654. 2005. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Zhang J, Wu GQ, Zhang Y, Feng ZY and Zhu
SM: Propofol induces apoptosis of hepatocellular carcinoma cells by
upregulation of microRNA-199a expression. Cell Biol Int.
37:227–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Siddiqui RA, Zerouga M, Wu M, et al:
Anticancer properties of propofol-docosahexaenoate and
propofol-eicosapentaenoate on breast cancer cells. Breast Cancer
Res. 7:R645–R654. 2005. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Wu RS, Liu KC, Tang NY, et al: cDNA
microarray analysis of the gene expression of murine leukemia RAW
264.7 cells after exposure to propofol. Environ Toxicol.
28:471–478. 2013. View Article : Google Scholar
|
28
|
Fan R, Zhong J, Zheng S, et al:
MicroRNA-218 inhibits gastrointestinal stromal tumor cell and
invasion by targeting KIT. Tumour Biol. 35:4209–4217. 2014.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Gao C, Zhang Z, Liu W, Xiao S, Gu W and Lu
H: Reduced microRNA-218 expression is associated with high nuclear
factor kappaB activation in gastric cancer. Cancer. 116:41–49.
2010.
|
30
|
He X, Dong Y, Wu CW, et al: MicroRNA-218
inhibits cell cycle progression and promotes apoptosis in colon
cancer by downregulating BMI1 polycomb ring finger oncogene. Mol
Med. 18:1491–1498. 2013.
|
31
|
Kinoshita T, Hanazawa T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion through targeting laminin-332 in head and neck squamous
cell carcinoma. Oncotarget. 3:1386–1400. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yamamoto N, Kinoshita T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
33
|
Yamasaki T, Seki N, Yoshino H, et al:
MicroRNA-218 inhibits cell migration and invasion in renal cell
carcinoma through targeting caveolin-2 involved in focal adhesion
pathway. J Urol. 190:1059–1068. 2013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Tu Y, Gao X, Li G, et al: MicroRNA-218
inhibits glioma invasion, migration, proliferation and cancer
stem-like cell self-renewal by targeting the polycomb group gene
Bmil. Cancer Res. 73:6046–6055. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Ishikawa M, Tanaka S, Arai M, Genda Y and
Sakamoto A: Differences in microRNA changes of healthy rat liver
between sevoflurane and propofol anesthesia. Anesthesiology.
117:1245–1252. 2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Rundhaug JE: Matrix metalloproteinases,
angiogenesis and cancer: commentary re: A. C. Lockhart et al:
Reduction of wound angiogenesis in patients treated with
BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.
Clin Cancer Res. 9:551–554. 2003.PubMed/NCBI
|
37
|
Deryugina EI, Bourdon MA, Luo GX, Reisfeld
RA and Strongin A: Matrix metalloproteinase-2 activation modulates
glioma cell migration. J Cell Sci. 110:2473–2482. 1997.PubMed/NCBI
|
38
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852005. View Article : Google Scholar : PubMed/NCBI
|